Scoop

Automating regulatory submissions for life sciences

scooplabs.ai

Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.

About

We’re building AI agents that speed up drug trials by automating the manual consolidation and document prep required for every IND submission. Today, biotechs spend months stitching together reports from contractors and internal teams just to file and get to their first-in-human trial. Scoop is a Y Combinator company (Fall 2025). YC-listed status: Active.

Location
San Francisco, CA, USA
Added via
web
Ownership
unclaimed

Where to go

Products

  • Scoop — AI platform that converts study and manufacturing data into IND submission-ready regulatory documents with full traceability and continuous maintenance. · Saas · Enterprise

Links